These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 226700)

  • 1. Role of E-type prostaglandins in the regulation of interferon-treated macrophage cytotoxic activity.
    Schultz RM; Stoychkov JN; Pavlidis N; Chirigos MA; Olkowski ZL
    J Reticuloendothel Soc; 1979 Jul; 26(1):93-102. PubMed ID: 226700
    [No Abstract]   [Full Text] [Related]  

  • 2. Factors affecting macrophage cytotoxic activity with particular emphasis on corticosteroids and acute stress.
    Schultz RM; Chirigos MA; Stoychkov JN; Pavlidis NA
    J Reticuloendothel Soc; 1979 Jul; 26(1):83-92. PubMed ID: 490511
    [No Abstract]   [Full Text] [Related]  

  • 3. Cytotoxic activity of interferon-treated macrophages studied by various inhibitors.
    Schultz RM; Pavlidis NA; Stylos WA; Chirigos MA
    Cancer Treat Rep; 1978 Nov; 62(11):1889-92. PubMed ID: 728906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of macrophage tumoricidal activity by agents known to increase cellular cyclic AMP.
    Schultz RM; Pavlidis NA; Stoychkov JN; Chirigos MA
    Cell Immunol; 1979 Jan; 42(1):71-8. PubMed ID: 219958
    [No Abstract]   [Full Text] [Related]  

  • 5. Regulation of macrophage tumoricidal function: a role for prostaglandins of the E series.
    Schultz RM; Pavlidis NA; Stylos WA; Chirigos MA
    Science; 1978 Oct; 202(4365):320-1. PubMed ID: 694537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of cyclic AMP in modulating cytotoxic T lymphocytes. I. In-vivo-generated cytotoxic lymphocytes, but not in vitro-generated cytotoxic lymphocytes, are inhibited by cyclic AMP-active agents.
    Plaut M
    J Immunol; 1979 Aug; 123(2):692-701. PubMed ID: 222842
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effect of cAMP modifiers on the cytotoxic activity of macrophages].
    Neskoromnyĭ AG; Goriukhina OA; Vasil'ev VIu
    Biokhimiia; 1987 Mar; 52(3):484-92. PubMed ID: 2437966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphokine maintains macrophage activation for tumor cell killing by interfering with the negative regulatory effect of prostaglandin E2.
    Taffet SM; Pace JL; Russell SW
    J Immunol; 1981 Jul; 127(1):121-4. PubMed ID: 6263971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of cyclic AMP in modulating cytotoxic T lymphocytes. II. Sequential changes during culture in responsiveness of cytotoxic lymphocytes to cyclic AMP-active agents.
    Plaut M; Marone G; Gillespie E
    J Immunol; 1983 Dec; 131(6):2945-52. PubMed ID: 6315818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interactions between prostaglandin E2 and prostacyclin in regulating levels of cyclic AMP in elicited populations of peritoneal macrophages.
    Bonta IL; Adolfs MJ
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 12():13-7. PubMed ID: 6303080
    [No Abstract]   [Full Text] [Related]  

  • 11. Augmentation of PGE1 sensitivity in macrophages by concanavalin A.
    Gemsa D; Steggemann L; Till G; Resch K
    Monogr Allergy; 1977; 12():155-8. PubMed ID: 199835
    [No Abstract]   [Full Text] [Related]  

  • 12. PGE1 and prostacyclin suppression of NK-cell mediated cytotoxicity and its relation to cyclic AMP.
    Lanefelt F; Ullberg M; Jondal M; Fredholm BB
    Med Biol; 1983; 61(6):324-30. PubMed ID: 6328136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of immunogenicity and production of ornithine by peritoneal macrophages.
    Kriegbaum H; Benninghoff B; Häcker-Shahin B; Dröge W
    J Immunol; 1987 Aug; 139(3):899-904. PubMed ID: 3110288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of tumor-derived cytokines on the immune system of mice bearing a mammary adenocarcinoma. II. Down-regulation of macrophage-mediated cytotoxicity by tumor-derived granulocyte-macrophage colony-stimulating factor.
    Sotomayor EM; Fu YX; Lopez-Cepero M; Herbert L; Jimenez JJ; Albarracin C; Lopez DM
    J Immunol; 1991 Oct; 147(8):2816-23. PubMed ID: 1918995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of the production of immune interferon and cytotoxic T lymphocytes by interleukin 2.
    Farrar WL; Johnson HM; Farrar JJ
    J Immunol; 1981 Mar; 126(3):1120-5. PubMed ID: 6161959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of murine natural killer cell activity by prostaglandins.
    Brunda MJ; Herberman RB; Holden HT
    J Immunol; 1980 Jun; 124(6):2682-7. PubMed ID: 6154736
    [No Abstract]   [Full Text] [Related]  

  • 17. [The trigger function of cAMP in the suppression of macrophage cytolytic activity].
    Vasil'ev VIu; Neskoromnyĭ AG; Goriukhina OA
    Dokl Akad Nauk SSSR; 1986; 290(6):1506-9. PubMed ID: 2433115
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparative effects of various classes of mouse interferons on macrophage activation for tumor cell killing.
    Pace JL; Russell SW; LeBlanc PA; Murasko DM
    J Immunol; 1985 Feb; 134(2):977-81. PubMed ID: 2578167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macrophage-mediated tumor cell killing: regulation of expression of cytolytic activity by prostaglandin E.
    Taffet SM; Russell SW
    J Immunol; 1981 Feb; 126(2):424-7. PubMed ID: 7451984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of natural killer-derived cytotoxic T lymphocytes. I. Regulation by macrophage and prostaglandins.
    Ting CC; Hargrove ME
    J Immunol; 1983 Oct; 131(4):1734-41. PubMed ID: 6604751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.